uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness

Summary

Prospective study to evaluate the value of uPAR-targeted PET/MR scan using the tracer 68Ga-NOTA-AE105 in patients with newly diagnosed prostate cancer

Timeline

Start

2017-11-21

Primary completion

2019-10-11

Completion

2022-04-01

Drugs

Indications